Search - tctmd.com

Displaying 301 - 320 of 1423

Sort: Relevancy | Date

Presentation TCT 2017

TCT 104: Initial Pre-clinical and Clinical Use of Mechanical Intracardiac Echocardiography System With 3D Viewing, Color Doppler, and Side-Viewing Capabilities

Presenter: Brij Maini, Petr Neuzil, Brian Courtney, MD

October 31, 2017

Presentation TCT 2017

RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis

Presenter: Thomas F. Luscher, Fernando Alfonso

October 31, 2017

Presentation TCT 2017

Bioresorbable Scaffolds One Year After Approval: FDA Perspectives on Current and Future BRS

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Andrew Farb

October 31, 2017

Presentation TCT 2017

Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

Presenter: Jean-Claude Laborde, Eric Van Belle, Lars Sondergaard

October 31, 2017

Presentation TCT 2017

TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Presentation TCT 2017

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

Presenter: Stephan Achenbach, Jacques J. Koolen, Stefan Verheye

October 31, 2017

Presentation TCT 2017

ILUMIEN III: 1-Year Outcomes From a Randomized Trial of OCT-Guided vs IVUS-Guided vs Angiography-Guided Stent Implantation

Presenter: Thomas F. Luscher, Ziad A. Ali

October 31, 2017

Presentation TCT 2017

FDA Perspectives on Short DAPT IDE Trials

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee

October 31, 2017

Presentation TCT 2017

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

Presenter: Stephan Achenbach, Jacques J. Koolen, Bo Xu

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

Presenter: Justin E. Davies, Bernard De Bruyne, Gabriele Pesarini, MD

October 31, 2017

Presentation TCT 2017

TCT 84: Procedural Strategy and Clinical Outcomes in Patients Undergoing PCI for Left Main Trifurcation Disease: The EXCEL Trial

Presenter: David Hildick-Smith, Nicholas J. Lembo, David E. Kandzari

October 31, 2017

Presentation TCT 2017

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

Presenter: Thomas F. Luscher, David Erlinge

October 31, 2017

Presentation TCT 2017

ReASSESS: Diagnostic Accuracy of FFRCT and SPECT Perfusion Imaging Compared to FFR in Patients With Coronary Artery Disease

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Niels Peter Rønnow Sand

October 31, 2017

Presentation TCT 2017

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Standard vs Novel DES and DAPT Duration

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Ajay J. Kirtane

October 31, 2017

Presentation TCT 2017

TCT 29: Mechanism of Low Fractional Flow Reserve in Lesions Without Angiographic Significant Stenosis: Role of Hidden Plaque Burden

Presenter: Justin E. Davies, Bernard De Bruyne, Jonghanne Park, MD

October 31, 2017

Presentation TCT 2017

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Stephan Achenbach, Jacques J. Koolen, Ron Waksman

October 31, 2017

Presentation TCT 2017

XINSORB: A Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Thomas F. Luscher, Junbo Ge

October 31, 2017

Presentation TCT 2017

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Marie-Claude Morice

October 31, 2017

Advertisement

TCT 104: Initial Pre-clinical and Clinical Use of Mechanical Intracardiac Echocardiography System With 3D Viewing, Color Doppler, and Side-Viewing Capabilities

RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis

Bioresorbable Scaffolds One Year After Approval: FDA Perspectives on Current and Future BRS

Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS

TCT 39: Clinical Outcomes in SURTAVI Based on Revascularization Stratification

TCT 31: Hybrid iFR-FFR Decision-Making Strategy in Coronary Revascularization of Patients With Severe Aortic Stenosis Undergoing TAVI

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

ILUMIEN III: 1-Year Outcomes From a Randomized Trial of OCT-Guided vs IVUS-Guided vs Angiography-Guided Stent Implantation

FDA Perspectives on Short DAPT IDE Trials

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

TCT 30: Instantaneous Wave-Free Period Variations after Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis

TCT 84: Procedural Strategy and Clinical Outcomes in Patients Undergoing PCI for Left Main Trifurcation Disease: The EXCEL Trial

VALIDATE-SWEDEHEART NSTEMI: A Randomized Trial of Bivalirudin vs Heparin Monotherapy in Patients With NSTEMI

ReASSESS: Diagnostic Accuracy of FFRCT and SPECT Perfusion Imaging Compared to FFR in Patients With Coronary Artery Disease

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Standard vs Novel DES and DAPT Duration

TCT 29: Mechanism of Low Fractional Flow Reserve in Lesions Without Angiographic Significant Stenosis: Role of Hidden Plaque Burden

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

XINSORB: A Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

The High-Bleeding-Risk Patient: Physician-Scientist Perspectives on Appropriate Patients and DAPT Duration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content